NASDAQ : LYEL
Lyell Immunopharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.83 USD (Oct 30, 2026, 2:17 PM EDT) · Market cap 265.39M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Lyell Immunopharma, Inc. (LYEL) reported revenue of 27.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 27.00K | 36.00K | 61.00K | 130.00K | 84.68M | 10.65M |
| Gross Profit | 27.00K | 36.00K | 61.00K | 130.00K | 84.68M | 10.65M |
| Selling, General & Admin | 40.43M | 45.13M | 52.04M | 66.98M | 117.31M | 89.06M |
| Research & Development | 156.50M | 158.68M | 171.60M | 182.94M | 159.19M | 138.69M |
| Other Operating Expenses | -6.45M | -5.49M | -4.65M | -4.30M | -4.86M | -3.53M |
| Operating Expenses | 190.49M | 198.32M | 218.99M | 245.63M | 271.64M | 224.22M |
| Operating Income | -190.46M | -198.28M | -218.93M | -245.50M | -186.96M | -213.57M |
| Interest & Investment Income | 10.32M | 13.08M | 24.07M | 23.45M | 7.05M | 1.17M |
| Other Non Operating Income (Expenses) | -1.96M | -19.83M | 890.00K | 1.85M | 1.89M | 95.00K |
| EBT Excluding Unusual Items | -182.10M | -205.03M | -193.97M | -220.20M | -178.01M | -212.31M |
| Gain (Loss) on Sale of Investments | 28.00K | -13.00M | -12.92M | -5.00M | -36.70M | |
| Gain (Loss) on Sale of Assets | 298.00K | -3.34M | -1.34M | -1.51M | -103.00K | -1.21M |
| Asset Writedown | -1.44M | -51.30M | ||||
| Other Unusual Items | -369.00K | 1.71M | 3.80M | |||
| Pretax Income | -248.48M | -274.45M | -342.99M | -234.63M | -183.12M | -250.22M |
| Net Income | -248.48M | -274.45M | -342.99M | -234.63M | -183.12M | -250.22M |
| Net Income to Common | -248.48M | -274.45M | -342.99M | -234.63M | -183.12M | -250.22M |
| Shares Outstanding (Basic) | 21.02M | 17.09M | 13.07M | 12.55M | 12.35M | 6.80M |
| Shares Outstanding (Diluted) | 21.02M | 17.09M | 13.07M | 12.55M | 12.35M | 6.80M |
| EPS (Basic) | -11.82 | -16.06 | -26.23 | -18.70 | -14.82 | -36.82 |
| EPS (Diluted) | -11.82 | -16.06 | -26.23 | -18.70 | -14.82 | -36.82 |
| Free Cash Flow | -133.97M | -150.80M | -162.86M | -166.38M | -193.83M | -191.75M |
| Free Cash Flow Per Share | -6.37 | -8.82 | -12.46 | -13.26 | -15.69 | -28.22 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -705,411.11% | -550,791.67% | -358,906.56% | -188,845.39% | -220.77% | -2,005.31% |
| Profit Margin | -920,285.18% | -762,355.56% | -562,285.25% | -180,486.15% | -216.24% | -2,349.47% |
| Free Cash Flow Margin | -496,188.89% | -418,900.00% | -266,980.33% | -127,984.62% | -228.89% | -1,800.50% |
| EBITDA | -180.94M | -186.75M | -199.30M | -225.25M | -168.94M | -199.94M |
| EBITDA Margin | -199.49% | |||||
| D&A For EBITDA | 9.52M | 11.54M | 19.63M | 20.25M | 18.02M | 13.62M |
| EBIT | -190.46M | -198.28M | -218.93M | -245.50M | -186.96M | -213.57M |
| EBIT Margin | -220.77% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 72.98M | 60.18M | 105.60M | 145.65M | 123.55M | 293.83M |
| Short-Term Investments | 131.12M | 187.04M | 264.93M | 400.58M | 516.60M | 320.97M |
| Cash & Short-Term Investments | 204.10M | 247.22M | 370.53M | 546.22M | 640.15M | 614.79M |
| Prepaid Expenses | 9.44M | 13.72M | 9.07M | 8.46M | 11.14M | 11.49M |
| Total Current Assets | 213.54M | 260.94M | 379.59M | 554.69M | 651.29M | 626.29M |
| Property, Plant & Equipment | 47.29M | 53.64M | 72.94M | 142.32M | 166.26M | 166.64M |
| Long-Term Investments | 42.90M | 19.00M | 32.01M | 48.51M | 115.04M | 330.53M |
| Other Long-Term Assets | 7.43M | 6.47M | 6.31M | 4.52M | 4.96M | 3.95M |
| Total Assets | 311.15M | 340.05M | 490.86M | 750.03M | 937.56M | 1.13B |
| Accounts Payable | 3.88M | 2.89M | 5.37M | 4.82M | 3.92M | 3.21M |
| Accrued Expenses | 25.82M | 20.94M | 29.37M | 20.36M | 21.14M | 22.36M |
| Current Portion of Leases | 9.66M | 9.07M | 7.97M | 6.27M | 4.53M | 1.17M |
| Current Unearned Revenue | 2.54M | 483.00K | 4.99M | |||
| Other Current Liabilities | 500.00K | 13.97M | 10.60M | 3.07M | 7.44M | 15.01M |
| Total Current Liabilities | 39.87M | 49.41M | 53.79M | 34.52M | 37.03M | 46.74M |
| Long-Term Leases | 36.93M | 41.92M | 50.99M | 56.89M | 63.17M | 66.65M |
| Long-Term Unearned Revenue | 79.67M | |||||
| Other Long-Term Liabilities | 537.00K | 517.00K | 3.25M | 3.66M | 4.11M | 4.57M |
| Total Liabilities | 77.34M | 91.85M | 108.03M | 95.08M | 104.31M | 197.62M |
| Common Stock | 2.00K | 2.00K | 1.00K | 25.00K | 25.00K | 24.00K |
| Additional Paid-In Capital | 1.92B | 1.87B | 1.73B | 1.66B | 1.61B | 1.52B |
| Retained Earnings | -1.69B | -1.62B | -1.35B | -1.00B | -767.48M | -584.36M |
| Comprehensive Income & Other | -158.00K | 242.00K | 291.00K | -94.00K | -7.60M | -1.62M |
| Total Common Equity | 233.81M | 248.20M | 382.82M | 654.95M | 833.25M | 929.79M |
| Shareholders' Equity | 233.81M | 248.20M | 382.82M | 654.95M | 833.25M | 929.79M |
| Total Liabilities & Equity | 311.15M | 340.05M | 490.86M | 750.03M | 937.56M | 1.13B |
| Total Debt | 46.60M | 50.99M | 58.97M | 63.17M | 67.70M | 67.82M |
| Net Cash (Debt) | 181.40M | 196.23M | 324.57M | 499.56M | 642.57M | 830.51M |
| Net Cash Per Share | 8.63 | 11.48 | 24.83 | 39.81 | 52.01 | 122.21 |
| Filing Date Shares Outstanding | 24.51M | 23.31M | 14.76M | 12.70M | 12.48M | 12.14M |
| Total Common Shares Outstanding | 23.40M | 21.25M | 14.74M | 12.70M | 12.48M | 12.14M |
| Working Capital | 173.67M | 211.53M | 325.81M | 520.17M | 614.27M | 579.55M |
| Book Value Per Share | 9.99 | 11.68 | 25.97 | 51.58 | 66.78 | 76.61 |
| Tangible Book Value | 233.81M | 248.20M | 382.82M | 654.95M | 833.25M | 929.79M |
| Tangible Book Value Per Share | 9.99 | 11.68 | 25.97 | 51.58 | 66.78 | 76.61 |
| Machinery | 28.86M | 39.02M | 35.85M | 34.33M | 29.03M | |
| Construction In Progress | 452.00K | 241.00K | 128.00K | 4.15M | 10.58M | |
| Leasehold Improvements | 79.74M | 79.61M | 118.32M | 116.93M | 95.00M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -248.48M | -274.45M | -342.99M | -234.63M | -183.12M | -250.22M |
| Depreciation & Amortization | 9.52M | 11.54M | 19.63M | 20.25M | 18.02M | 13.62M |
| Loss (Gain) From Sale of Assets | -298.00K | 3.34M | 1.34M | 1.51M | 103.00K | 1.21M |
| Asset Writedown & Restructuring Costs | 66.33M | 67.78M | 138.48M | |||
| Loss (Gain) From Sale of Investments | 15.41M | 14.26M | -1.71M | 3.33M | 1.15M | 38.35M |
| Stock-Based Compensation | 39.63M | 41.83M | 33.14M | 47.08M | 81.92M | 62.20M |
| Other Operating Activities | -21.21M | -4.42M | -7.17M | -4.65M | -5.62M | 4.57M |
| Change in Accounts Payable | 465.00K | -2.34M | -3.23M | 1.46M | 667.00K | 91.00K |
| Change in Unearned Revenue | -84.65M | -10.51M | ||||
| Change in Other Net Operating Assets | 5.38M | -7.55M | 114.00K | 1.96M | 1.97M | 14.43M |
| Operating Cash Flow | -133.26M | -150.02M | -162.39M | -163.69M | -169.56M | -126.25M |
| Capital Expenditures | -711.00K | -780.00K | -464.00K | -2.69M | -24.28M | -65.50M |
| Sale of Property, Plant & Equipment | 292.00K | 287.00K | ||||
| Cash Acquisitions | -41.20M | -41.20M | -31.35M | |||
| Investment in Securities | 46.59M | 95.78M | 154.23M | 186.73M | 12.74M | -56.07M |
| Investing Cash Flow | 4.98M | 54.10M | 122.42M | 184.05M | -11.54M | -121.57M |
| Issuance of Common Stock | 102.47M | 50.41M | 1.40M | 2.20M | 11.10M | 401.24M |
| Repurchase of Common Stock | -1.00K | -1.00K | -76.00K | -457.00K | -461.00K | |
| Financing Cash Flow | 102.47M | 50.41M | 1.33M | 1.74M | 10.63M | 401.24M |
| Net Cash Flow | -25.82M | -45.52M | -38.64M | 22.10M | -170.46M | 153.42M |
| Free Cash Flow | -133.97M | -150.80M | -162.86M | -166.38M | -193.83M | -191.75M |
| Free Cash Flow Margin | -496,188.89% | -418,900.00% | -266,980.33% | -127,984.62% | -228.89% | -1,800.50% |
| Free Cash Flow Per Share | -6.37 | -8.82 | -12.46 | -13.26 | -15.69 | -28.22 |
| Levered Free Cash Flow | -72.81M | -81.47M | -67.56M | -90.36M | -53.90M | -129.82M |
| Unlevered Free Cash Flow | -72.81M | -81.47M | -67.56M | -90.36M | -53.90M | -129.82M |
| Change in Working Capital | 5.84M | -9.89M | -3.12M | 3.42M | -82.02M | 4.01M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 266.62M | 653.89M | 186.98M | 488.63M | 865.16M | 1.86B |
| Enterprise Value | 85.22M | 387.34M | -215.10M | -44.90M | 181.98M | 992.05M |
| Last Close Price | 10.88 | 30.78 | 12.80 | 38.80 | 69.40 | 154.80 |
| PS Ratio | 9,874.66 | 18,163.58 | 3,065.30 | 3,758.66 | 10.22 | 174.76 |
| PB Ratio | 1.09 | 2.63 | 0.49 | 0.75 | 1.04 | 2.00 |
| P/TBV Ratio | 1.14 | 2.63 | 0.49 | 0.75 | 1.04 | 2.00 |
| EV/Sales Ratio | 3,156.15 | 10,759.39 | 2.15 | 93.15 | ||
| Debt / Equity Ratio | 0.20 | 0.20 | 0.15 | 0.10 | 0.08 | 0.07 |
| Net Debt / Equity Ratio | -0.78 | -0.79 | -0.85 | -0.76 | -0.77 | -0.89 |
| Net Debt / EBITDA Ratio | 1.00 | 1.05 | 1.63 | 2.22 | 3.80 | 4.15 |
| Net Debt / FCF Ratio | 1.35 | 1.30 | 1.99 | 3.00 | 3.31 | 4.33 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.01 |
| Quick Ratio | 5.12 | 5.00 | 6.89 | 15.82 | 17.29 | 13.15 |
| Current Ratio | 5.36 | 5.28 | 7.06 | 16.07 | 17.59 | 13.40 |
| Return on Equity (ROE) | -93.28% | -86.98% | -66.10% | -31.53% | -20.77% | -30.36% |
| Return on Assets (ROA) | -34.18% | -29.83% | -22.05% | -18.18% | -11.32% | -13.11% |
| Return on Capital Employed (ROCE) | -70.20% | -68.20% | -50.10% | -34.30% | -20.80% | -19.80% |
| Earnings Yield | -108.66% | -41.97% | -183.44% | -48.02% | -21.17% | -13.44% |
| FCF Yield | -50.25% | -23.06% | -87.10% | -34.05% | -22.40% | -10.30% |
| Buyback Yield / Dilution | -49.16% | -30.74% | -4.18% | -1.58% | -81.79% | -925.18% |